Masaki Ueno

Masaki Ueno

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in HPB
Verified
Journal Article
Closed access
HIHiroya Iida
Hiroya Iida
MTMasaji Tani
Masaji Tani
KKKoji Komeda
Koji Komeda
TNTakeo Nomi
Takeo Nomi
HMHideyuki Matsushima
Hideyuki Matsushima
SKShoji Kubo
Shoji Kubo

1 March 2020 in EBioMedicine
Verified
Journal Article
Open access
MFMasashi Fujita
Masashi Fujita
RYRui Yamaguchi
Rui Yamaguchi
THTakanori Hasegawa
Takanori Hasegawa
SSShu Shimada
Shu Shimada
KAKoji Arihiro
Koji Arihiro
HNHidewaki Nakagawa
Hidewaki Nakagawa
The tumor microenvironment can be classified into immunologically active "inflamed" tumors and inactive "non-inflamed" tumors based on the infiltration of cytotoxic immune cells. Previous studies on liver cancer have reported a superior prognosis for inflamed tumors compared to non-inflamed tumors. However, liver cancer is highly heterogeneous immunologically and genetically, and a finer classification of the liver cancer microenvironment may improve our understanding of its immunological diversity and response to immune therapy. We characterized the immune gene signatures of 234 primary liver cancers, mainly virus-related, from a Japanese population using RNA-Seq of tumors and matched non-tumorous hepatitis livers. We then compared them with the somatic alterations detected using the whole-genome sequencing. Liver cancers expressed lower levels of immune marker genes than non-tumorous hepatitis livers, indicating immunosuppression in the tumor microenvironment. Several immunosuppression mechanisms functioned actively and mutually exclusively, resulting in four immune subclasses of liver cancer: tumor-associated macrophage (TAM), CTNNB1, cytolytic activity (CYT), and regulatory T cell (Treg). The CYT and Treg subclasses represented inflamed tumors, while the TAM and CTNNB1 subclasses represented non-inflamed tumors. The TAM subclass, which comprised 31% of liver cancers, showed a poor survival, expressed elevated levels of extracellular matrix genes, and was associated with somatic mutations of chromatin regulator ARID2. The results of cell line experiments suggested a functional link between ARID2 and chemokine production by liver cancer cells. Primary liver cancer was classified into four subclasses based on mutually exclusive mechanisms for immunosuppression. This classification indicate the importance of immunosuppression mechanisms, such as TAM and Treg, as therapeutic targets for liver cancer. The Japan Agency for Medical Research and Development (AMED).

12 February 2014 in Journal of Hepato-Biliary-Pancreatic Sciences
Verified
Journal Article
Open access
PDF file
TUTakahiro Uenishi
Takahiro Uenishi
SAShunichi Ariizumi
Shunichi Ariizumi
TATaku Aoki
Taku Aoki
TETomoki Ebata
Tomoki Ebata
MOMasayuki Ohtsuka
Masayuki Ohtsuka
TTTadahiro Takada
Tadahiro Takada
Background Recently, the Liver Cancer Study Group of Japan (LCSGJ) staging system for intrahepatic cholangiocarcinoma (ICC) was followed by a proposal of the American Committee on Cancer (AJCC)/International Union Against Cancer (UICC) system. The present study aimed to assess the accuracy of both systems to predict survival after curative resection for mass‐forming ICC and to establish a new staging system based on survival analysis results. The present study was conducted as a project study of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery. Methods Clinical data from 233 patients who underwent curative resection for mass‐forming ICC were retrospectively reviewed. Survival analysis was performed to identify predictors of postoperative outcomes, and a new staging system was established. The survival stratification of our proposed system was compared with two previous staging systems. Results A N0M0 cohort analysis demonstrated that tumor size, tumor number, and vascular invasion were independently associated with survival after curative resection for mass‐forming ICC, whereas serosal and periductal invasion were not. Of patients with nodal metastases, patients with T4 tumor had significantly lower overall survival rate than patients with T1, T2, or T3 tumor. Thus, we proposed a new staging system as follows: serosal invasion was excluded from the LCSGJ T categories, and patients with nodal metastases were divided into stage IVA or IVB according to T classification. The new system better stratified survival after curative resection for mass‐forming ICC than the two previous systems. Conclusions The AJCC/UICC staging system failed to stratify the Japanese patients with mass‐forming ICC. The new staging system provided better survival prediction in the patients who underwent curative resection for mass‐forming ICC, although further studies are necessary to evaluate the impact of tumor size on survival.


11 May 2021 in Annals of Gastroenterological Surgery
Verified
Journal Article
Open access
PDF file
HIHiroya Iida
Hiroya Iida
MTMasaji Tani
Masaji Tani
FHFumitoshi Hirokawa
Fumitoshi Hirokawa
MUMasaki Ueno
Masaki Ueno
TNTakehiro Noda
Takehiro Noda
SKShoji Kubo
Shoji Kubo
Background: Although several risk factors for incisional hernia after hepatectomy have been reported, their relationship to different wound sites has not been investigated. Therefore, this study aimed to examine the risk factors for incisional hernia according to various wound sites after hepatectomy.Methods: Patients from the Osaka Liver Surgery Study Group who underwent open hepatectomy using combinations of vertical and horizontal incisions (J‐shaped incision, reversed L‐shaped incision, reversed T‐shaped incision, Mercedes incision) between January 2012 and December 2015 were included. Incisional hernia was defined as a hernia occurring within 3 y after surgery. Abdominal incisional hernia was classified into midline incisional hernia and transverse incisional hernia. The risk factors for each posthepatectomy incisional hernia type were identified.Results: A total of 1057 patients met the inclusion criteria. The overall posthepatectomy incisional hernia incidence rate was 5.9% (62 patients). In the multivariate analysis, the presence of diabetes mellitus and albumin levels <3.5 g/dL were identified as independent risk factors. Moreover, incidence rates of midline and transverse incisional hernias were 2.4% (25 patients), and 2.3% (24 patients), respectively. In multivariate analysis, the independent risk factor for transverse incisional hernia was the occurrence of superficial or deep incisional surgical site infection, and interrupted suturing for midline incisional hernia.Conclusions: Risk factors for incisional hernia after hepatectomy depend on the wound site. To prevent incisional hernia, running suture use might be better for midline wound closure. The prevention of postoperative wound infection is important for transverse wounds, under the presumption of preoperative nutrition and normoglycemia.

16 November 2022 in Surgery
Verified
Journal Article
Closed access
MKManabu Kawai
Manabu Kawai
KOKen-Ichi Okada
Ken-Ichi Okada
MMMotoki Miyazawa
Motoki Miyazawa
YKYuji Kitahata
Yuji Kitahata
HMHideki Motobayashi
Hideki Motobayashi
HYHiroki Yamaue
Hiroki Yamaue